Archives of Neuroscience

Published by: Kowsar

Demographic Analysis of Patients With Multiple Sclerosis; Individual Variability Related to the Time Interval

Zahra Tolou-Ghamari 1 , *
Author Information
1 Isfahan Neurosciences Research Centre, Faculty of Medicine, Isfahan University of Medical Sciences, Isfahan, IR Iran
Article information
  • Archives of Neuroscience: July 01, 2015, 2 (3); e21806
  • Published Online: July 20, 2015
  • Article Type: Research Article
  • Received: July 6, 2014
  • Revised: November 19, 2014
  • Accepted: December 9, 2014
  • DOI: 10.5812/archneurosci.21806

To Cite: Tolou-Ghamari Z. Demographic Analysis of Patients With Multiple Sclerosis; Individual Variability Related to the Time Interval, Arch Neurosci. 2015 ; 2(3):e21806. doi: 10.5812/archneurosci.21806.

Abstract
Copyright © 2015, Tehran University of Medical Sciences. This is an open-access article distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 International License (http://creativecommons.org/licenses/by-nc/4.0/) which permits copy and redistribute the material just in noncommercial usages, provided the original work is properly cited.
1. Background
2. Objectives
3. Patients and Methods
4. Results
5. Discussion
Acknowledgements
Footnote
References
  • 1. Laks J, Ahlgren C, Oden A, Lycke J. High Nationwide Incidence of Multiple Sclerosis in Sweden. PLoS ONE. 2014; 9(9)-599
  • 2. Methley AM, Chew-Graham C, Campbell S, Cheraghi-Sohi S. Experiences of UK health-care services for people with Multiple Sclerosis: a systematic narrative review. Health Expect. 2014; : 12-3
  • 3. Tullman MJ. Overview of the epidemiology, diagnosis, and disease progression associated with multiple sclerosis. Am J Manag Care. 2013; 19(2 Suppl)-20[PubMed]
  • 4. Evans C, Beland S, Kulaga S, Wolfson C, Kingwell E, Marriott J, et al. Incidence and Prevalence of Multiple Sclerosis in the Americas: A Systematic. Neuroepidemiology. 2013; 40: 195-210
  • 5. Tolou-Ghamari Z, Shaygannejad V, Ashtari F. Preliminary study related the incidence of methylprednisolone pulse therapy in patients visited multiple sclerosis clinic located at the isfahan kashani hospital. Int J Prev Med. 2013; 4-8[PubMed]
  • 6. Ozcan ME, Ince B, Bingol A, Erturk S, Altinoz MA, Karadeli HH, et al. Association between smoking and cognitive impairment in multiple sclerosis. Neuropsychiatr Dis Treat. 2014; 10: 1715-9[DOI][PubMed]
  • 7. Gaber TA, Oo WW, Ringrose H. Multiple Sclerosis/Chronic Fatigue Syndrome overlap: When two common disorders collide. NeuroRehabilitation. 2014; 35(3): 529-34[DOI][PubMed]
  • 8. Gianfrancesco MA, Acuna B, Shen L, Briggs FBS, Quach H, Bellesis KH, et al. Obesity during childhood and adolescence increases susceptibility to multiple sclerosis after accounting for established genetic and environmental risk factors. Obesity Res Clin Pract . 2014; 8(5)-47[DOI]
  • 9. Weinstock JV, Elliott DE. Helminth infections decrease host susceptibility to immune-mediated diseases. J Immunol. 2014; 193(7): 3239-47[DOI][PubMed]
  • 10. Friede T, Eloyan A, Shou H, Shinohara RT, Sweeney EM, Nebel MB, et al. Health Effects of Lesion Localization in Multiple Sclerosis: Spatial Registration and Confounding Adjustment. PLoS ONE. 2014; 9(9)-263[DOI]
  • 11. Vitkova M, Gdovinova Z, Rosenberger J, Szilasiova J, Nagyova I, Mikula P, et al. Factors associated with poor sleep quality in patients with multiple sclerosis differ by disease duration. Disability Health J. 2014; 7(4): 466-71[DOI]
  • 12. Roos PM. Osteoporosis in neurodegeneration. J Trace Elements Med Biol. 2014; 28(4): 418-21[DOI]
  • 13. Etemadifar M, Sajjadi S, Nasr Z, Firoozeei TS, Abtahi SH, Akbari M, et al. Epidemiology of multiple sclerosis in Iran: a systematic review. Eur Neurol. 2013; 70(5-6): 356-63[DOI][PubMed]
  • 14. Goodin DS. Glucocorticoid treatment of multiple sclerosis. Handb Clin Neurol. 2014; 122: 455-64[PubMed]
  • 15. Fernandez-Jaen A, Fernández-Mayoralas DM, Fernández-Perrone AL, Jimenez de la Pena M, Recio Rodriguez M, Calleja-Perez B, et al. Cortical thickness at the time of the initial attack in two patients with paediatric relapsing–remitting multiple sclerosis. Eur J Paediatr Neurol. 2014; 18(3): 295-300[DOI]
  • 16. Ramagopalan SV, Mowry EM, Carey RF, Blasco MR, Pelletier J, Duquette P, et al. Association of Multiple Sclerosis Susceptibility Variants and Early Attack Location in the CNS. PLoS ONE. 2013; 8(10)-65[DOI]
  • 17. Citro A, Barnaba V, Martini H. From T Cell Apoptosis to Chronic Immune Activation in Inflammatory Diseases. Int Arch Allergy Immunol . 2014; 164(2): 140-6
  • 18. Zahednasab H, Balood M, Harirchian MH, Mesbah-Namin SA, Rahimian N, Siroos B. Increased autotaxin activity in multiple sclerosis. J Neuroimmunology. 2014; 273(1-2): 120-3[DOI]
  • 19. Bsibsi M, Peferoen LAN, Holtman IR, Nacken PJ, Gerritsen WH, Witte ME, et al. Demyelination during multiple sclerosis is associated with combined activation of microglia/macrophages by IFN-γ and alpha B-crystallin. Acta Neuropathologica. 2014; 128(2): 215-29[DOI]
  • 20. Turkoglu R, Gencer M, Ekmekci D, Ulusoy C, Erdag E, Sehitoglu E, et al. Switch-Associated Protein 70 Antibodies in Multiple Sclerosis: Possible Association with Disease Progression. Med Principles Pract. 2014; 23(3): 239-45[DOI]
  • 21. Malik MT, Healy BC, Benson LA, Kivisakk P, Musallam A, Weiner HL, et al. Factors associated with recovery from acute optic neuritis in patients with multiple sclerosis. Neurology. 2014; 82(24): 2173-9
  • 22. Shaygannejad V, Tolou-Ghamari Z. What is the Real Fate of Vitamin D in Multiple Sclerosis? Int J Prev Med. 2013; 4-64[PubMed]
  • 23. Campbell GR, Worrall JT, Mahad DJ. The central role of mitochondria in axonal degeneration in multiple sclerosis. Mult Scler. 2014; 20(14): 1806-13[DOI][PubMed]
Creative Commons License Except where otherwise noted, this work is licensed under Creative Commons Attribution Non Commercial 4.0 International License .
Readers' Comments